A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection

Mostrar otras versiones (1)

Broadly neutralizing antibodies (bnAbs) to coronaviruses (CoVs) are valuable in their own right as prophylactic and therapeutic reagents to treat diverse CoVs and, importantly, as templates for rational pan-CoV vaccine design. We recently described a bnAb, CC40.8, from a coronavirus disease 2019 (CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Panpan, Yuan, Meng, Song, Ge, Beutler, Nathan, Shaabani, Namir, Huang, Deli, He, Wan-ting, Zhu, Xueyong, Callaghan, Sean, Yong, Peter, Anzanello, Fabio, Peng, Linghang, Ricketts, James, Parren, Mara, Garcia, Elijah, Rawlings, Stephen A., Smith, Davey M., Nemazee, David, Teijaro, John R., Rogers, Thomas F., Wilson, Ian A., Burton, Dennis R., Andrabi, Raiees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020973/
https://www.ncbi.nlm.nih.gov/pubmed/33821273
http://dx.doi.org/10.1101/2021.03.30.437769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020973/
https://www.ncbi.nlm.nih.gov/pubmed/33821273
http://dx.doi.org/10.1101/2021.03.30.437769

Ejemplares similares